FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3096430081> ?p ?o ?g. }

• W3096430081 endingPage "102560" @default.
• W3096430081 startingPage "102560" @default.
• W3096430081 abstract "Animal models and few clinical reports suggest the involvement of the complement system in the onset of severe manifestations of coronavirus disease-2019 (COVID-19). However, complement contribution to endotheliopathy and hypercoagulability has not been elucidated yet. To evaluate the association among complement activation, endothelial damage and disease severity or activity in COVID-19 patients. In this single-centre cohort study, 148 patients with COVID-19 of different severity were evaluated upon hospital admission and 30 days later. Markers of complement activation (SC5b-9 and C5a) and endothelial perturbation (von Willebrand factor [vWF], tissue-type plasminogen activator [t-PA], plasminogen activator inhibitor-1 [PAI-1], soluble thrombomodulin [sTM], and soluble endothelial selectin [sE-selectin]) were measured in plasma. The patients had high plasma levels of SC5b-9 and C5a (p = 0.0001 for both) and vWF, t-PA and PAI-1 (p = 0.0001 for all). Their SC5b-9 levels correlated with those of vWF (r = 0.517, p = 0.0001) and paralleled disease severity (severe vs mild p = 0.0001, severe vs moderate p = 0.026 and moderate vs mild p = 0.001). The levels of sE-selectin were significantly increased only in the patients with severe disease. After 30 days, plasma SC5b-9, C5a and vWF levels had significantly decreased (p = 0.0001 for all), and 43% of the evaluated patients had normal levels. Complement activation is boosted during the progression of COVID-19 and dampened during remission, thus indicating its role in the pathophysiology of the disease. The association between complement activation and the biomarkers of endothelial damage suggests that complement may contribute to tissue injury and could be the target of specific therapy." @default.
• W3096430081 created "2020-11-09" @default.
• W3096430081 creator A5001839117 @default.
• W3096430081 creator A5004487731 @default.
• W3096430081 creator A5012908783 @default.
• W3096430081 creator A5020576282 @default.
• W3096430081 creator A5029089981 @default.
• W3096430081 creator A5043797998 @default.
• W3096430081 creator A5044914610 @default.
• W3096430081 creator A5050004441 @default.
• W3096430081 creator A5050497878 @default.
• W3096430081 creator A5051944867 @default.
• W3096430081 creator A5053473631 @default.
• W3096430081 creator A5056105834 @default.
• W3096430081 creator A5061604257 @default.
• W3096430081 creator A5061651325 @default.
• W3096430081 creator A5064631193 @default.
• W3096430081 creator A5066258002 @default.
• W3096430081 creator A5069417319 @default.
• W3096430081 creator A5071587401 @default.
• W3096430081 creator A5075247997 @default.
• W3096430081 creator A5077454624 @default.
• W3096430081 creator A5079672940 @default.
• W3096430081 creator A5089723648 @default.
• W3096430081 creator A5091506479 @default.
• W3096430081 date "2021-01-01" @default.
• W3096430081 modified "2023-09-23" @default.
• W3096430081 title "Complement activation and endothelial perturbation parallel COVID-19 severity and activity" @default.
• W3096430081 cites W1557940991 @default.
• W3096430081 cites W1602285939 @default.
• W3096430081 cites W2060772557 @default.
• W3096430081 cites W2098821817 @default.
• W3096430081 cites W2120657538 @default.
• W3096430081 cites W2163243965 @default.
• W3096430081 cites W2166673618 @default.
• W3096430081 cites W2167724179 @default.
• W3096430081 cites W2591992124 @default.
• W3096430081 cites W2898080189 @default.
• W3096430081 cites W2910405468 @default.
• W3096430081 cites W2942790287 @default.
• W3096430081 cites W3001897055 @default.
• W3096430081 cites W3007559338 @default.
• W3096430081 cites W3008461878 @default.
• W3096430081 cites W3008827533 @default.
• W3096430081 cites W3009885589 @default.
• W3096430081 cites W3012952745 @default.
• W3096430081 cites W3013486442 @default.
• W3096430081 cites W3014003872 @default.
• W3096430081 cites W3015607499 @default.
• W3096430081 cites W3016123694 @default.
• W3096430081 cites W3016965546 @default.
• W3096430081 cites W3017125154 @default.
• W3096430081 cites W3020740293 @default.
• W3096430081 cites W3025680240 @default.
• W3096430081 cites W3027918021 @default.
• W3096430081 cites W3040254875 @default.
• W3096430081 cites W3040924356 @default.
• W3096430081 cites W3045715678 @default.
• W3096430081 cites W3047564875 @default.
• W3096430081 cites W3047719754 @default.
• W3096430081 cites W3087862874 @default.
• W3096430081 cites W3088256443 @default.
• W3096430081 doi "https://doi.org/10.1016/j.jaut.2020.102560" @default.
• W3096430081 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7598768" @default.
• W3096430081 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33139116" @default.
• W3096430081 hasPublicationYear "2021" @default.
• W3096430081 type Work @default.
• W3096430081 sameAs 3096430081 @default.
• W3096430081 citedByCount "112" @default.
• W3096430081 countsByYear W30964300812020 @default.
• W3096430081 countsByYear W30964300812021 @default.
• W3096430081 countsByYear W30964300812022 @default.
• W3096430081 countsByYear W30964300812023 @default.
• W3096430081 crossrefType "journal-article" @default.
• W3096430081 hasAuthorship W3096430081A5001839117 @default.
• W3096430081 hasAuthorship W3096430081A5004487731 @default.
• W3096430081 hasAuthorship W3096430081A5012908783 @default.
• W3096430081 hasAuthorship W3096430081A5020576282 @default.
• W3096430081 hasAuthorship W3096430081A5029089981 @default.
• W3096430081 hasAuthorship W3096430081A5043797998 @default.
• W3096430081 hasAuthorship W3096430081A5044914610 @default.
• W3096430081 hasAuthorship W3096430081A5050004441 @default.
• W3096430081 hasAuthorship W3096430081A5050497878 @default.
• W3096430081 hasAuthorship W3096430081A5051944867 @default.
• W3096430081 hasAuthorship W3096430081A5053473631 @default.
• W3096430081 hasAuthorship W3096430081A5056105834 @default.
• W3096430081 hasAuthorship W3096430081A5061604257 @default.
• W3096430081 hasAuthorship W3096430081A5061651325 @default.
• W3096430081 hasAuthorship W3096430081A5064631193 @default.
• W3096430081 hasAuthorship W3096430081A5066258002 @default.
• W3096430081 hasAuthorship W3096430081A5069417319 @default.
• W3096430081 hasAuthorship W3096430081A5071587401 @default.
• W3096430081 hasAuthorship W3096430081A5075247997 @default.
• W3096430081 hasAuthorship W3096430081A5077454624 @default.
• W3096430081 hasAuthorship W3096430081A5079672940 @default.
• W3096430081 hasAuthorship W3096430081A5089723648 @default.
• W3096430081 hasAuthorship W3096430081A5091506479 @default.
• W3096430081 hasBestOaLocation W30964300811 @default.

• next